Today, an analysis that may challenge ASCVD guidelines, a new formula may predict adverse events from NSAIDs, a potentially important myocardial infarction risk factor is identified, and a diabetes drug gets a new cardiovascular indication.
Subscribe to Cardiocast wherever you get your podcasts.
Amazon Alexa
Apple Podcasts